U.S. to scrutinize foreign biotech investments

The U.S. government will scrutinize foreign investments in biotech companies and block those it deems threats to national security under interim regulations released Wednesday.

Biotech is included among 27 “critical technology” areas included in a pilot program to extend the reach of the Committee of Foreign Investment in the United States (CFIUS), the Treasury Department announced in an interim rule...